Lindsey Rolfe, See Remarks at Clovis Oncology, Inc. (CLVS), sold 661 shares at $6.29 ($4K) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Seasonal sale ($4k) by See Remarks — this insider has traded CLVS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.29 | 315 | $2K | 47.7% |
| 2 | $6.29 | 346 | $2K | 52.3% |
| Total | $6.29 avg | 661 | $4K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $8K | — | Filing → |